High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
1 Analyst Rating
Wall Street analysts forecast EUDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EUDA is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.900
Low
6.00
Averages
6.00
High
6.00
Current: 2.900
Low
6.00
Averages
6.00
High
6.00
No Data
Valuation Metrics
The current forward P/E ratio for EUDA Health Holdings Ltd (EUDA.O) is 50.43, compared to its 5-year average forward P/E of -12.44. For a more detailed relative valuation and DCF analysis to assess EUDA Health Holdings Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-12.44
Current PE
50.43
Overvalued PE
15.44
Undervalued PE
-40.32
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-4.21
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.41
Undervalued EV/EBITDA
-9.84
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
7.26
Current PS
0.00
Overvalued PS
12.98
Undervalued PS
1.54
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
EUDA News & Events
Events Timeline
(ET)
2025-10-23
09:03:57
EUDA Health's CK Health Plus Forms Alliance with SafeRock India
2025-10-20 (ET)
2025-10-20
09:05:28
EUDA Health's Subsidiary Receives Direct Selling License
2025-09-10 (ET)
2025-09-10
09:32:34
EUDA Health Enters LOI for Possible Acquisition of GO POSB
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
7.5
10-23NewsfilterCK Health Plus, a Subsidiary of EUDA, Enters Indian Market Through Strategic Alliance with SafeRock India
Preview
8.5
08-28NewsfilterEUDA Expresses Interest in Potential Acquisition of Chemokine Pte Ltd Through Letter of Intent
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/cd21d868099dca89d3e2a5bed11f47ed7950ae0ca75f66a0e2b306c4d20b8485.png)
Preview
4.5
08-27TipRanksTuesday's Major Stock Market Highlights: Morning News Summary!
Sign Up For More News
People Also Watch
FAQ
What is EUDA Health Holdings Ltd (EUDA) stock price today?
What is EUDA Health Holdings Ltd (EUDA)'s business?
What is the price predicton of EUDA Stock?
What is EUDA Health Holdings Ltd (EUDA)'s revenue for the last quarter?
What is EUDA Health Holdings Ltd (EUDA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for EUDA Health Holdings Ltd (EUDA)'s fundamentals?
How many employees does EUDA Health Holdings Ltd (EUDA). have?